You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Estimating the clinical cost of drug development for orphan versus non-orphan drugs
|
|---|---|
| Published in |
Orphanet Journal of Rare Diseases, January 2019
|
| DOI | 10.1186/s13023-018-0990-4 |
| Pubmed ID | |
| Authors |
Kavisha Jayasundara, Aidan Hollis, Murray Krahn, Muhammad Mamdani, Jeffrey S. Hoch, Paul Grootendorst |
X Demographics
The data shown below were collected from the profiles of 39 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 5 | 13% |
| Spain | 3 | 8% |
| United States | 3 | 8% |
| Netherlands | 2 | 5% |
| South Africa | 2 | 5% |
| India | 2 | 5% |
| France | 1 | 3% |
| United Kingdom | 1 | 3% |
| Sweden | 1 | 3% |
| Other | 0 | 0% |
| Unknown | 19 | 49% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 29 | 74% |
| Scientists | 9 | 23% |
| Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 258 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 258 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 37 | 14% |
| Student > Master | 33 | 13% |
| Student > Bachelor | 32 | 12% |
| Researcher | 23 | 9% |
| Other | 19 | 7% |
| Other | 40 | 16% |
| Unknown | 74 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 29 | 11% |
| Medicine and Dentistry | 29 | 11% |
| Biochemistry, Genetics and Molecular Biology | 28 | 11% |
| Agricultural and Biological Sciences | 14 | 5% |
| Economics, Econometrics and Finance | 13 | 5% |
| Other | 59 | 23% |
| Unknown | 86 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 62. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 February 2024.
All research outputs
#699,024
of 25,655,374 outputs
Outputs from Orphanet Journal of Rare Diseases
#64
of 3,163 outputs
Outputs of similar age
#15,960
of 448,421 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#1
of 53 outputs
Altmetric has tracked 25,655,374 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,163 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,421 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.